Lenz Therapeutics Stock Market Value
| LENZ Stock | 35.50 1.18 3.44% |
| Symbol | LENZ |
LENZ Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LENZ Therapeutics. If investors know LENZ will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LENZ Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.74) | Return On Assets (0.77) | Return On Equity (1.58) |
The market value of LENZ Therapeutics is measured differently than its book value, which is the value of LENZ that is recorded on the company's balance sheet. Investors also form their own opinion of LENZ Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is LENZ Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LENZ Therapeutics' market value can be influenced by many factors that don't directly affect LENZ Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LENZ Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if LENZ Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LENZ Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
LENZ Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to LENZ Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of LENZ Therapeutics.
| 02/29/2024 |
| 11/25/2024 |
If you would invest 0.00 in LENZ Therapeutics on February 29, 2024 and sell it all today you would earn a total of 0.00 from holding LENZ Therapeutics or generate 0.0% return on investment in LENZ Therapeutics over 270 days. LENZ Therapeutics is related to or competes with Eliem Therapeutics, HCW Biologics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. LENZ Therapeutics is entity of United States More
LENZ Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure LENZ Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess LENZ Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.22 | |||
| Information Ratio | 0.149 | |||
| Maximum Drawdown | 23.95 | |||
| Value At Risk | (6.63) | |||
| Potential Upside | 8.04 |
LENZ Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for LENZ Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as LENZ Therapeutics' standard deviation. In reality, there are many statistical measures that can use LENZ Therapeutics historical prices to predict the future LENZ Therapeutics' volatility.| Risk Adjusted Performance | 0.1445 | |||
| Jensen Alpha | 0.4968 | |||
| Total Risk Alpha | 0.0818 | |||
| Sortino Ratio | 0.1622 | |||
| Treynor Ratio | 0.3156 |
LENZ Therapeutics Backtested Returns
LENZ Therapeutics appears to be not too volatile, given 3 months investment horizon. LENZ Therapeutics has Sharpe Ratio of 0.18, which conveys that the firm had a 0.18% return per unit of volatility over the last 3 months. By evaluating LENZ Therapeutics' technical indicators, you can evaluate if the expected return of 0.86% is justified by implied risk. Please exercise LENZ Therapeutics' mean deviation of 3.41, and Risk Adjusted Performance of 0.1445 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, LENZ Therapeutics holds a performance score of 14. The company secures a Beta (Market Risk) of 2.55, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, LENZ Therapeutics will likely underperform. Please check LENZ Therapeutics' value at risk, as well as the relationship between the kurtosis and market facilitation index , to make a quick decision on whether LENZ Therapeutics' current price movements will revert.
Auto-correlation | 0.26 |
Poor predictability
LENZ Therapeutics has poor predictability. Overlapping area represents the amount of predictability between LENZ Therapeutics time series from 29th of February 2024 to 13th of July 2024 and 13th of July 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of LENZ Therapeutics price movement. The serial correlation of 0.26 indicates that nearly 26.0% of current LENZ Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.26 | |
| Spearman Rank Test | 0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 17.31 |
LENZ Therapeutics lagged returns against current returns
Autocorrelation, which is LENZ Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting LENZ Therapeutics' stock expected returns. We can calculate the autocorrelation of LENZ Therapeutics returns to help us make a trade decision. For example, suppose you find that LENZ Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
LENZ Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If LENZ Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if LENZ Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in LENZ Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
LENZ Therapeutics Lagged Returns
When evaluating LENZ Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of LENZ Therapeutics stock have on its future price. LENZ Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, LENZ Therapeutics autocorrelation shows the relationship between LENZ Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in LENZ Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for LENZ Stock Analysis
When running LENZ Therapeutics' price analysis, check to measure LENZ Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LENZ Therapeutics is operating at the current time. Most of LENZ Therapeutics' value examination focuses on studying past and present price action to predict the probability of LENZ Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LENZ Therapeutics' price. Additionally, you may evaluate how the addition of LENZ Therapeutics to your portfolios can decrease your overall portfolio volatility.